Chiome Bioscience Inc. (TYO:4583)
76.00
+1.00 (1.33%)
Nov 18, 2026, 10:20 AM JST
Chiome Bioscience Market Cap
Chiome Bioscience has a market cap or net worth of 6 billion as of November 17, 2026. It is the 32,138th most valuable company in the world and the 2,908th biggest in Japan. Its market cap has decreased by 28.34% in one year.
Market Cap
6.00B
Enterprise Value
4.69B
Revenue
615.15M
Global Rank
Country Rank
#2,908 Japan
PE Ratio
n/a
ChartMarket Cap Chart
Since December 20, 2011, Chiome Bioscience's market cap has increased from 470.00M to 6.00B, an increase of 1,176.11%. That is a compound annual growth rate of 18.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2026 | 6.00B | -17.62% |
| Dec 30, 2025 | 7.28B | -58.55% |
| Dec 30, 2024 | 17.56B | 149.35% |
| Dec 29, 2023 | 7.04B | -18.27% |
| Dec 30, 2022 | 8.62B | 9.67% |
| Dec 30, 2021 | 7.86B | 6.96% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ADR Biomedical Holdings | 7.14B |
| CellSeed | 6.68B |
| StemCell Institute | 6.56B |
| OncoTherapy Science | 6.53B |
| J-Pharma | 6.45B |
| TMS Co., Ltd. | 6.12B |
| Nano Holdings | 6.10B |
| CellSource | 5.60B |